Maria Aanesland Dahle winner of the NTNU award for Best Master of Technology 2022
The PROPHECY project is focused on large scale proteomic analyses of breast cancer patients in the I-BCT clinical trial.
In PROPHECY Maria is using both her wet-lab and computational skills to develop novel approaches for predicting and monitoring response to neoadjuvant treatment with chemotherapy supplemented with carboplatin.
Video presentation of the work earning her the award:
From the National Network for Breast Cancer Research:
I-BCT clinical trial
Home page of Mads H. Haugen's project group:
Molecular precision medicine in breast cancer
Home page of Gunhild Mælandsmo's research group:
Metastasis Biology and Experimental Therapeutics